Sharma AN, Michelle L, Juhasz M, et al. - In this systematic review, researchers sought to assess the use of oral minoxidil for all types of alopecia. Ten articles were involved for a review containing a total 19,218 patients (215 women and 19,003 men). The oral dose of minoxidil ranged from 0.25 to 5 mg daily to twice daily. The strongest evidence did exist for androgenetic alopecia and alopecia areata (AA), with 61–100% and 18–82.4% of patients showing objective clinical improvement. In addition, successful treatment of female pattern hair loss, chronic telogen effluvium, monilethrix, and permanent chemotherapy‐induced alopecia was reported. The authors concluded that oral minoxidil is a safe and successful treatment of androgenic alopecia and AA. Practical advantages over topical minoxidil stem from improved patient compliance in addition to its therapeutic benefits.